Analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens increased their price target on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st.
Get Our Latest Analysis on Veradigm
Veradigm Trading Up 1.9 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- What is the Australian Securities Exchange (ASX)
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- About the Markup Calculator
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- When to Sell a Stock for Profit or Loss
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.